Ultraviolet therapy may be coming to a hospital near you to help treat COVID-19 developed by Cedars-Sinai hospital in Los Angeles.
Healight Platform Technology has been exclusively licensed to Aytu BioScience Inc for worldwide commercial development and release which could mean that hospitals around the globe may soon adopt this approach.
According to some reports this method has been billed as being a potential “first-in-class treatment for coronavirus and other respiratory infections,” that utilizes proprietary methods of administering intermittent UVA light using a novel endotracheal device. Preclinical study findings are suggesting that this approach has the potential to help eradicate the spread of this COVID-19 outbreak, as well as “a wide range of viruses and bacteria, inclusive of coronavirus.”
